AGP Picks
View all

The Middle East Gazette
Provided by AGP

The Middle East Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Gazette.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 18, 2026

Clearmind Medicine Signs Agreement to Examine MEAI in Combination and Sequencing with Tirzepatide Against Blockbuster GLP-1 Medications
May 18, 2026

Clearmind Medicine Signs Agreement to Examine MEAI in Combination and Sequencing with Tirzepatide Against Blockbuster GLP-1 Medications

Indeterminate GlobeNewswire
Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution
May 18, 2026

Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution

Indeterminate GlobeNewswire
Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 18, 2026

Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Critical Metals Signs Definitive Agreement to Acquire European Lithium
May 18, 2026

Critical Metals Signs Definitive Agreement to Acquire European Lithium

Indeterminate GlobeNewswire
Teva Study Finds Only 23% of Younger Adults with Mood Disorders and Tardive Dyskinesia (TD) Symptoms Are Formally Diagnosed with TD Despite Widespread Impact
May 18, 2026

Teva Study Finds Only 23% of Younger Adults with Mood Disorders and Tardive Dyskinesia (TD) Symptoms Are Formally Diagnosed with TD Despite Widespread Impact

Indeterminate GlobeNewswire
Syneos Health Wins “Best Mobile App for Patient Engagement” in 2026 MedTech Breakthrough Awards
May 18, 2026

Syneos Health Wins “Best Mobile App for Patient Engagement” in 2026 MedTech Breakthrough Awards

Indeterminate GlobeNewswire
Kyverna Therapeutics Names Greg Martini as Chief Financial Officer
May 18, 2026

Kyverna Therapeutics Names Greg Martini as Chief Financial Officer

Indeterminate GlobeNewswire
Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
May 18, 2026

Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Indeterminate GlobeNewswire
BrainsWay Announces Minority-Stake Investment in Hopemark Health
May 18, 2026

BrainsWay Announces Minority-Stake Investment in Hopemark Health

Indeterminate GlobeNewswire
CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 18, 2026

CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire
NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation
May 18, 2026

NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation

Indeterminate GlobeNewswire
NervGen Reports First Quarter 2026 Financial Results and Provides Business Updates
May 18, 2026

NervGen Reports First Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire
Juniper Biosciences Appoints Renowned Radiopharmaceutical Expert Jason S. Lewis, Ph.D. as Chair of Newly Formed Scientific Advisory Board
May 18, 2026

Juniper Biosciences Appoints Renowned Radiopharmaceutical Expert Jason S. Lewis, Ph.D. as Chair of Newly Formed Scientific Advisory Board

Indeterminate GlobeNewswire
Scientific Publication of Can-Fite and Vetbiolix Validates Piclidenoson’s Potential in the Multi-Billion Dollar Canine Osteoarthritis Market
May 18, 2026

Scientific Publication of Can-Fite and Vetbiolix Validates Piclidenoson’s Potential in the Multi-Billion Dollar Canine Osteoarthritis Market

Indeterminate GlobeNewswire
Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
May 18, 2026

Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202

Indeterminate GlobeNewswire
Allot to Present at TD Cowen’s 54th Annual Technology, Media & Telecom Conference on May 27-28, 2026
May 18, 2026

Allot to Present at TD Cowen’s 54th Annual Technology, Media & Telecom Conference on May 27-28, 2026

Indeterminate GlobeNewswire
Cytovation to Evaluate Getacatetide (CY-101) in Combination with Checkpoint Inhibitor Tislelizumab in Colorectal Cancer
May 18, 2026

Cytovation to Evaluate Getacatetide (CY-101) in Combination with Checkpoint Inhibitor Tislelizumab in Colorectal Cancer

Indeterminate GlobeNewswire
Al Tamimi & Company Advises SALAMA on AED 155 Million Mandatory Convertible Sukuk to Strengthen Solvency Position
May 18, 2026

Al Tamimi & Company Advises SALAMA on AED 155 Million Mandatory Convertible Sukuk to Strengthen Solvency Position

Indeterminate GlobeNewswire

Share this page:

Sign up for:

The Middle East Gazette

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.